Dr. Michael Arya Daneshvar, MD, MS

Dr. Daneshvar practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Daneshvar's NPI, 1194103861, was assigned on May 13, 2015. Dr. Daneshvar graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2015. Dr. Daneshvar's Maryland license number on file is D0089555.

Dr. Daneshvar's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Daneshvar's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Center for Urological Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daneshvar practices. Vendor and product names are available with a free account.

Urology is Dr. Daneshvar's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Daneshvar is board certified in urology by the American Board of Urology. Dmand AI has Dr. Daneshvar's licenses on file in 3 states: Maryland, California and District of Columbia.

Dmand AI lists bladder removal, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, prostate surgery, urinary endoscopy and urine flow blockage among the conditions Dr. Daneshvar treats.

CMS data shows 1,158 Medicare services from Dr. Daneshvar across 16 procedure codes in 2024, for 362 Medicare patients. Medicare paid $144,810 for them.

CMS counts 362 Medicare patients who saw Dr. Daneshvar in 2024. The largest group is 65 to 74, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Daneshvar's median patient age at 68, with 20% women.

In 2024, Dr. Daneshvar wrote 180 Medicare Part D claims for 87 patients. 86% of them were for generic drugs. CMS names the drug for 117 of them, across 6 drugs with 11 or more claims each, at $15,175 in total drug cost. In 2023, CMS named 221 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Daneshvar for performance year 2024, reported through an alternative payment model (APM). Dr. Daneshvar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Daneshvar as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Daneshvar, published from 2010 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Kidney Neoplasms, Prostatic Neoplasms and Carcinoma, Renal Cell. Dr. Daneshvar has published most often in Cancers (Basel). Dr. Daneshvar's most frequent co-authors are Gennady Bratslavsky, MD, Peter Anthony Pinto, MD and Nataliya Mar, MD.

CMS Open Payments shows 154 general payments to Dr. Daneshvar from 26 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 37% of the total. Intuitive Surgical, Inc. paid the most, $18,165.

Dmand AI lists 1 award for Dr. Daneshvar, most recently M.D. with a Distinction in Research in 2015.

Dr. Daneshvar graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2015. Dr. Daneshvar is a member of AUA.

Dr. Daneshvar is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.